Peregrine Ventures brings total managed funds and co-invest capital to $400 Million

Eyal Lifschitz Peregrine Ventures just closed its fourth fund—Peregrine 4—raising $115 million. Their partners include some of the leading institutional and private equity investors from Israel, the USA, Europe and Australia. According to a press release, Peregrine now has more than $200 million under management and has an equal amount available for [...]

2019-12-09T13:10:06+00:00December 9th, 2019|Tags: , |

First patient enrolled in global clinical trial of Peregrine system kit for uncontrolled hypertension

Click edit button to change this text. Peregrine system kit Ablative Solutions has announced the enrolment and randomisation of the first patient in its TARGET BP I global clinical trial, which is evaluating Peregrine system kit for the treatment of patients with uncontrolled hypertension. The Peregrine system kit, which is comprised [...]

2019-07-30T13:55:34+00:00July 30th, 2019|Tags: , , |
Go to Top